Reduced functional expression of K(+) channels in vascular smooth muscle cells from rats made hypertensive with N{omega}-nitro-L-arginine

Am J Physiol Heart Circ Physiol. 2005 Sep;289(3):H1284-90. doi: 10.1152/ajpheart.01053.2004. Epub 2005 May 6.

Abstract

Smooth muscle membrane potential is determined, in part, by K(+) channels. In the companion paper to this article, we demonstrated that superior mesenteric arteries from rats made hypertensive with N(omega)-nitro-l-arginine (l-NNA) are depolarized and express less K(+) channel protein compared with those from normotensive rats. In the present study, we used patch-clamp techniques to test the hypothesis that l-NNA-induced hypertension reduces the functional expression of K(+) channels in smooth muscle. In whole cell experiments using a Ca(2+)-free pipette solution, current at 0 mV, largely due to voltage-dependent K(+) (K(V)) channels, was reduced approximately 60% by hypertension (2.7 +/- 0.4 vs. 1.1 +/- 0.2 pA/pF). Current at +100 mV with 300 nM free Ca(2+), largely due to large-conductance Ca(2+)-activated K(+) (BK(Ca)) channels, was reduced approximately 40% by hypertension (181 +/- 24 vs. 101 +/- 28 pA/pF). Current blocked by 3 mM 4-aminopyridine, an inhibitor of many K(V) channel types, was reduced approximately 50% by hypertension (1.0 +/- 0.4 vs. 0.5 +/- 0.2 pA/pF). Current blocked by 1 mM tetraethylammonium, an inhibitor of BK(Ca) channels, was reduced approximately 40% by hypertension (86 +/- 14 vs. 53 +/- 19 pA/pF). Differences in BK(Ca) current magnitude are not attributable to changes in single-channel conductance or Ca(2+)/voltage sensitivity. The data support the hypothesis that l-NNA-induced hypertension reduces K(+) current in vascular smooth muscle. Reduced molecular and functional expression of K(+) channels may partly explain the depolarization and augmented contractile sensitivity of smooth muscle from l-NNA-treated rats.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Delayed Rectifier Potassium Channels
  • Enzyme Inhibitors
  • Hypertension / chemically induced
  • Hypertension / physiopathology*
  • Male
  • Membrane Potentials / physiology
  • Muscle, Smooth, Vascular / physiology*
  • Nitric Oxide / metabolism
  • Nitroarginine
  • Patch-Clamp Techniques
  • Potassium Channels, Calcium-Activated / physiology*
  • Potassium Channels, Voltage-Gated / physiology*
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Delayed Rectifier Potassium Channels
  • Enzyme Inhibitors
  • Potassium Channels, Calcium-Activated
  • Potassium Channels, Voltage-Gated
  • Nitroarginine
  • Nitric Oxide